Install
FirstWord
- 112articles · 30d
- 14+ hour agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 13avg words
- Medical 92
- Health 75
- Health & Wellness 68
- Business & Industrial 39
- Economy, Business & Finance 25
- Finance & Business 16
- Science & Technology 10
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
WCLC26: GSK's ris-rez cuts death risk 54% in China Phase III lung cancer trial
21+ hour, 40+ min ago (16+ words) FirstWord Pharma...
Animal data trigger enrollment pause in Biohaven's epilepsy study
3+ day, 17+ hour ago (11+ words) FirstWord PHARMA...
Inhibrx touts HNSCC subgroup data, eyes accelerated pathway for OX40 agonist
5+ day, 13+ hour ago (13+ words) FirstWord Pharma...
Roivant's pulmonary hypertension drug mosliciguat scores mid-stage win
6+ day, 2+ hour ago (10+ words) FirstWord Pharma...
Novartis??? Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study
6+ day, 5+ hour ago (12+ words) Novartis’ Avidity-sourced del-desiran stumbles in Phase III myotonic dystrophy study FirstWord Pharma...
Novo's hopes for ziltivekimab dwindle as two heart failure studies stopped early
1+ week, 3+ hour ago (14+ words) FirstWord Pharma...
Novartis' pelacarsen fails critical cardiovascular test
1+ week, 2+ day ago (8+ words) FirstWord Pharma...
Owkin lands third major pharma partner in AI deal with Boehringer Ingelheim
1+ week, 4+ day ago (14+ words) FirstWord Pharma...
Roche nabs tri-specific antibody from Simcere in $1.5B deal
1+ week, 5+ day ago (11+ words) FirstWord Pharma...
Novartis' Rhapsido delivers dual Phase III wins in relapsing MS
1+ week, 5+ day ago (11+ words) firstwordpharma.com...